Seven years of the National Action League for People with Rare Diseases. NAMSE - a success story?!

被引:0
|
作者
Halbach, Alexandra [1 ]
Schnieders, Birgit [1 ]
Knufmann-Happe, Karin [1 ]
机构
[1] Bundesminist Gesundheit, Friedrichstr 108, D-10117 Berlin, Germany
关键词
Rare diseases; Action plan; NAMSE; Centers; Sustainability;
D O I
10.1007/s00103-017-2530-0
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
It is estimated that four million people in Germany are living with a rare disease; in the EU, approximately 30 million people are affected. All rare diseases are chronic, linked to invalidity and/or restricted life expectancy, and their symptoms are often already manifest in childhood. Some 80% of rare diseases are genetically determined; they can rarely be cured. Furthermore, the pathogenesis of many rare diseases is unknown. In a move to ameliorate the situation of persons with rare diseases, the National Action League for People with Rare Diseases (NAMSE) published the National Plan of Action for People with Rare Diseases containing 52 measures that aim to achieve the desired improvements. More than half of these measures have already been implemented or are currently in the process of implementation. The Federal Ministry of Health is supporting this implementation process with numerous projects. NAMSE has achieved a great deal as a result of the National Plan of Action for People with Rare Diseases, even though not all of the measures included in the National Plan of Action have been implemented. The first results of individual measures are already becoming apparent. In order to achieve long-lasting improvements in the prevention, diagnosis and therapy of rare diseases, initiatives will have to be coordinated in the future as well. The Federal Ministry of Health will be funding the NAMSE Coordinating Office until mid-2018, thus ensuring that NAMSE will remain operational until that time. All of the partners collaborating in the Action League agree on the need for NAMSE, together with its coordinating office, to remain in place. To this end, a structure that keeps the health care situation of persons with rare diseases under observation, that suggests solutions and offers a possibility for the parties involved to network, is necessary. The question of conducting a legal restructuring of NAMSE in the future that will be sustainable in the long term is currently under discussion.
引用
收藏
页码:479 / 486
页数:8
相关论文
共 36 条
  • [21] The Italian National Centre for Rare Diseases: where research and public health translate into action
    Taruscio, Domenica
    Agresta, Linda
    Amato, Annalisa
    Bernardo, Giuseppe
    Bernardo, Luana
    Braguti, Francesca
    Carbone, Pietro
    Carta, Claudio
    Ceccarini, Marina
    Censi, Federica
    Coppola, Simona
    Crialese, Patrizia
    De Santis, Marta
    Diemoz, Stefano
    Donati, Carlo
    Gainotti, Sabina
    Ferrari, Gianluca
    Floridia, Giovanna
    Frank, Claudio
    Frazzica, Rosa Giuseppa
    Gentile, Amalia E.
    Granata, Orietta
    Kodra, Yllka
    Latrofa, Manuela
    Laricchiuta, Paola
    Magrelli, Armando
    Morciano, Cristina
    Polizzi, Agata
    Razeto, Stefania
    Salvatore, Marco
    Sanseverino, Antonella
    Savini, Daniele
    Torreri, Paola
    Tosto, Fabrizio
    Villani, Flavia
    Vincenti, Giorgio
    Vittozzi, Luciano
    BLOOD TRANSFUSION, 2014, 12 : S591 - S605
  • [22] Leveraging donor support to develop a national antimicrobial resistance policy and action plan: Ghana's success story
    Opintan, Japheth A.
    AFRICAN JOURNAL OF LABORATORY MEDICINE, 2018, 7 (02)
  • [23] Round table 1 State of play after 10 or 15 years of action for rare diseases
    Cottet, Christian
    Dollfus, Helene
    Forget, Sylvain
    Hanauer, Marc
    M S-MEDECINE SCIENCES, 2016, 32 : 8 - 11
  • [24] National and European concepts for the bundling of expertise for rare diseases. Part 2: Concentration and networking in Europe: centers of excellence and reference networks
    Voigtlaender, Till
    Ladurner, Joy
    PADIATRIE UND PADOLOGIE, 2015, 50 : S74 - S80
  • [25] Evolution of national and European policies in the field of rare diseases and their impact over the past five years
    Charlotte Rodwell
    Ségolène Aymé
    Orphanet Journal of Rare Diseases, 9 (Suppl 1)
  • [26] Resource consumption of a structured transition of young people with rare diseases from pediatric to adult care in a German nationwide cohort Effort and cost analysis from the TRANSLATE-NAMSE project
    Grasemann, C.
    Hoeppner, J.
    Burgard, P.
    Matar, N.
    Hoffmann, G. F.
    Mueller, G.
    Berner, R.
    Lee-Kirsch, M.
    Wainwright, K.
    Baumgarten, S.
    Weiler-Normann, C.
    Choukair, D.
    MONATSSCHRIFT KINDERHEILKUNDE, 2022, 170 (01) : 29 - 37
  • [27] Clinical Exome Sequencing, an Effective Tool for Detecting Causative Mutations for Rare Diseases: Retrospective Study of the Past Seven Years
    Eno, C. C.
    Lee, H.
    Deignan, J. L.
    Nelson, S. F.
    Grody, W. W.
    JOURNAL OF MOLECULAR DIAGNOSTICS, 2019, 21 (06): : 1127 - 1127
  • [28] se-atlas - the health service information platform for people with rare diseases. Supporting research on medical care institutions and support groups
    Haase, Johanna
    Wagner, Thomas O. F.
    Storf, Holger
    BUNDESGESUNDHEITSBLATT-GESUNDHEITSFORSCHUNG-GESUNDHEITSSCHUTZ, 2017, 60 (05) : 503 - 509
  • [29] Impact of the COVID-19 Pandemic on People Living With Rare Diseases and Their Families: Results of a National Survey
    Macaluso, Maurizio
    Rothenberg, Marc E.
    Ferkol, Thomas
    Kuhnell, Pierce
    Kaminski, Henry J.
    Kimberlin, David W.
    Benatar, Michael
    Chehade, Mirna
    JMIR PUBLIC HEALTH AND SURVEILLANCE, 2024, 10
  • [30] Measures to improve the health situation of patients with rare diseases in Germany. A comparison with the National Action Plan
    Frank, M.
    Eidt-Koch, D.
    Aumann, I.
    Reimann, A.
    Wagner, T. O. F.
    von der Schulenburg, J. -M. Graf
    BUNDESGESUNDHEITSBLATT-GESUNDHEITSFORSCHUNG-GESUNDHEITSSCHUTZ, 2014, 57 (10) : 1216 - 1223